Safflower oil body nanoparticles deliver hFGF10 to hair follicles and reduce microinflammation to accelerate hair regeneration in androgenetic alopecia.
Androgenetic alopecia
Follicular microinflammation
Follicular penetration
SOB-hFGF10
Journal
International journal of pharmaceutics
ISSN: 1873-3476
Titre abrégé: Int J Pharm
Pays: Netherlands
ID NLM: 7804127
Informations de publication
Date de publication:
25 Mar 2022
25 Mar 2022
Historique:
received:
26
10
2021
revised:
19
01
2022
accepted:
29
01
2022
pubmed:
13
2
2022
medline:
15
3
2022
entrez:
12
2
2022
Statut:
ppublish
Résumé
Androgenetic alopecia (AGA) affects physical and mental health with limited therapeutic options. Novel materials and delivery methods have considerable potential to improve the current paradigm of treatment. In this study, we used a novel plant nanoparticle of safflower oil body (SOB) loaded with human fibroblast growth factor 10 (hFGF10) to target hair follicles and accelerate hair regeneration in AGA mice with few adverse effects. Our data revealed that the average particle size of SOB-hFGF10 was 226.73 ± 9.98 nm, with a spherical and uniform structure, and that SOB-hFGF10 was quicker to preferentially penetrate into hair follicles than hFGF2 alone. Using a mouse model of AGA, SOB-hFGF10 was found to significantly improve hair regeneration without any significant toxicity. Furthermore, SOB-hFGF10 inhibited dihydrotestosterone (DHT)-induced TNF-α, IL-1β, and IL-6 overproduction in macrophages in relation to hair follicle microinflammation, thereby enhancing the proliferation of dermal papilla cells. Overall, this study provides an applicable therapeutic method through targeting hair follicles and reducing microinflammation to accelerate hair regeneration in AGA.
Identifiants
pubmed: 35150848
pii: S0378-5173(22)00091-6
doi: 10.1016/j.ijpharm.2022.121537
pii:
doi:
Substances chimiques
Fibroblast Growth Factor 10
0
Safflower Oil
8001-23-8
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
121537Informations de copyright
Copyright © 2022 Elsevier B.V. All rights reserved.